Physician

Philip S Blum, MD

According to 2025 Medicare claims, Philip Blum, MD (NPI: 1568444115) practices neurology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is MHS PHYSICIANS OF TEXAS (NPI: 1184714867; TIN: 760385980) and primary practice location at 77024-2574. Blum is affiliated with the Memorial Hermann Accountable Care Organization (ACO ID: A1175), participating under the MSSP model.

Blum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 620 traditional Medicare patients, billed 247,908 HCPCS/CPT codes, and received $4,053,564 in Medicare payments. The top billing code was 95912 (Nerve conduction, 11-12 studies). Part D data shows 1,245 prescription claims across 345 beneficiaries totaling $1,147,479 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2023 DME data shows 26 claims. Open Payments data shows 2 records totaling $53. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $392,231 to $4,053,564. Similarly, Part D prescription costs have risen steadily, from $239,670 to $1,147,479. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,333 and ending at $5,546.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	304	14,543	$392,231
2016	443	23,050	$652,181
2017	623	16,187	$681,150
2018	590	19,072	$748,977
2019	757	34,758	$1,300,557
2020	738	36,341	$1,318,863
2021	761	57,782	$2,341,269
2022	778	89,038	$3,251,394
2023	660	93,547	$3,368,532
2024	620	247,908	$4,053,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	1,650	$239,670
2016	256	1,831	$379,001
2017	317	1,797	$307,450
2018	382	1,931	$351,977
2019	364	1,644	$355,900
2020	362	1,376	$333,758
2021	380	1,300	$501,815
2022	352	1,165	$543,842
2023	298	1,017	$675,299
2024	345	1,245	$1,147,479

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$159
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	100	$12,861
2022	N/R	N/R	N/R
2023	N/R	26	$175,108
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95912	Nerve conduction, 11-12 studies	49	49	$184
95911	Nerve conduction, 9-10 studies	45	45	$175
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	165	165	$130
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	120	154	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	338	$78

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	41	945	$414,038
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	16	448	$240,235
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	21	588	$205,760
Aimovig Autoinjector	Erenumab-Aooe	39	1,498	$35,435
Carbidopa-Levodopa	Carbidopa/Levodopa	127	7,554	$2,803

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$53	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Philip S. Blum, MD?

Tedicare shows public-source Medicare data for Philip S. Blum, MD (NPI 1568444115), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip S. Blum, MD have ACO affiliation data?

Philip S. Blum, MD is shown with ACO affiliation data for Memorial Hermann Accountable Care Organization (MSSP, ACO ID A1175).

What billing organization is linked to Philip S. Blum, MD?

Philip S. Blum, MD is linked to MHS PHYSICIANS OF TEXAS (billing NPI 1184714867) in the available physician profile data.

Does Philip S. Blum, MD have Open Payments data?

Philip S. Blum, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.